https://www.selleckchem.com/products/bmh-21.html
Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Less prevalent is euglycemic DKA (eDKA)-DKA with serum glucose less than 200 mg/dL; however, it is increasing in frequency with the introduction of sodium glucose cotransporter 2 (SGLT-2) inhibitors for treatment of type 2 diabetes. We report a case of SGLT-2 inhibitor-associated eDKA presenting with concurrent acute pericarditis. Our case suggests that the cause of eDKA can be multifactorial when decreased oral intake occurs in the setting o
Me gusta
Comentario
Compartir
